Theo Ai names Bristol Myers Squibb ex-counsel to board

Theo Ai, a litigation defense intelligence platform serving in-house counsel and Am Law 200 firms, announced the appointment of Sandra Leung to its Board of Directors. Leung is the retired Executive Vice President and General Counsel of Bristol Myers Squibb, one of the world's largest pharmaceutical companies.

Leung's 32-year career at Bristol Myers Squibb began in 1992 as a staff attorney in the litigation department. She ascended to General Counsel in February 2007, where she led the company's worldwide Law Department, overseeing litigation, intellectual property, corporate governance, securities, and compliance and ethics. Her track record earned her recognition as one of America's Top 50 General Counsel by the National Law Journal in 2014 and 2016, and she received the New York City Bar Association's Diversity & Inclusion Champion Award in 2020. She currently serves on the boards of the Asian American Legal Defense and Education Fund and the Minority Corporate Counsel Association, and chairs the Governance Committee of Bausch Health Systems.

Leung had been advising Theo Ai since November 2025 as a member of its General Counsel Advisory Board, where she helped shape the company's understanding of how enterprise legal teams evaluate litigation risk, governance, and responsible AI. Patrick Ip, co-founder and CEO of Theo Ai, stated: "Sandra ran the legal team at one of the largest pharmaceutical companies in the world, managing litigation risk at a scale few executives ever reach. Her perspective gives Theo Ai something especially important as we build for enterprise legal teams: the judgment of a GC who has lived the pressures our customers face. She will help ensure our AI is not only powerful, but practical, responsible, and grounded in the litigation challenges and enterprise risks Fortune 500 companies manage every day."

Leung expressed her enthusiasm for the board role, highlighting Theo Ai's strength in helping legal teams navigate complex matters: "What impressed me most about Theo Ai is its ability to help legal teams separate the signal from the noise—especially in complex matters involving voluminous medical records. Having led legal teams through high-stakes enterprise risk, I see tremendous potential for Theo Ai to help teams review information more thoroughly, develop strategy faster, and make better-informed decisions." She added, "I want to help Theo Ai build with the same discipline I expected from my own legal teams—practical, defensible, and built for how in-house counsel actually make decisions under pressure."

The announcement coincides with Theo Ai's expansion of its executive team. Pamela Fehring, who holds a JD and CIPP/US certification, has been named Head of Product Marketing. Her role focuses on connecting Theo Ai's litigation intelligence capabilities to the strategic, operational, and governance needs of enterprise legal teams, helping GCs and litigation heads understand how the platform supports matter assessment, litigation strategy, risk management, and responsible AI deployment. Fehring brings 12 years of experience from U.S. Bank, where she most recently served as Chief AI Counsel and previously held roles as VP, Assistant General Counsel for AI & Data Analytics and for Privacy, Data Initiatives & Platforms. She is recognized as an award-winning legal AI innovator and national speaker on AI governance and data ethics.

Theo Ai's platform transforms case updates, documents, and outside counsel reporting into attributed summaries, portfolio analytics, reserve recommendations, one-click reports, and exposure and settlement benchmarks, enabling legal teams to understand portfolio risk with greater visibility, consistency, and speed across case strategy, reserves, reporting, and resolution planning.

Theo Ai's appointment of Sandra Leung reflects a deliberate strategy to ground its litigation intelligence platform in the real-world pressures that Fortune 500 legal teams face. Leung's three-decade arc at Bristol Myers Squibb—from litigation attorney to General Counsel overseeing worldwide legal operations—positions her to advise on product design and strategy informed by the scale and complexity of enterprise risk management. By elevating her from the advisory board (formed November 2025) to the Board of Directors, Theo Ai signals that customer perspective is embedded in its highest governance.

The parallel appointment of Pamela Fehring as Head of Product Marketing extends this grounding into the go-to-market dimension. Fehring's 12-year track record at U.S. Bank in AI governance, privacy, and compliance roles—including as Chief AI Counsel—brings both technical credibility and a lawyer's understanding of how in-house counsel evaluate and adopt AI tools. Her mandate to connect Theo Ai's capabilities to the strategic and operational needs of enterprise legal teams suggests the company is moving beyond a technology pitch toward a business case anchored in how GCs and litigation heads actually work under pressure.

No comments yet. Be the first to share your thoughts!